Market Cap ₹162 Cr.
Stock P/E 15.6
P/B 1.5
Current Price ₹202.7
Book Value ₹ 137.3
Face Value 10
52W High ₹484.4
Dividend Yield 0%
52W Low ₹ 177.1
Nirman Agri Genetics Limited (NAGL) is a public company that provides agri-input products and services in India. Incorporated in 2020, it has a focus on research and development, production, processing, and marketing of hybrid seeds, pesticides, bio-organic, and other commodities. They have completed several projects across India and delivered quality and timely work. It has a registered office in Nashik and a corporate office in New Delhi. Its website is nirmanagri.com. The company’s promoter is Pranav Kailas Bagal, who holds 66.05% of the shareholding. They were the first company in India to introduce hybrid seeds for sunflower and grain sorghum.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 11 | 13 | 19 | 20 | 50 | 62 | 61 | 63 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 11 | 13 | 19 | 20 | 50 | 62 | 61 | 63 |
Total Expenditure | 0 | 0 | 9 | 11 | 16 | 17 | 45 | 55 | 54 | 56 |
Operating Profit | 0 | 0 | 2 | 2 | 3 | 4 | 5 | 7 | 7 | 7 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 2 | 2 | 3 | 3 | 5 | 7 | 7 | 7 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 2 | 2 | 3 | 3 | 5 | 6 | 7 | 7 |
Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 2 | 2 | 3 | 3 | 5 | 6 | 7 | 7 |
Adjusted Earnings Per Share | 0 | 0 | 3.1 | 3.5 | 5.3 | 5.6 | 8.4 | 8 | 8.4 | 8.6 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|
Net Sales | 4 | 13 | 29 | 63 | 236 |
Other Income | 0 | 0 | 0 | 0 | 0 |
Total Income | 4 | 13 | 29 | 63 | 236 |
Total Expenditure | 4 | 10 | 24 | 52 | 210 |
Operating Profit | 0 | 3 | 4 | 11 | 26 |
Interest | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 3 | 4 | 11 | 26 |
Provision for Tax | 0 | 1 | 0 | 1 | 0 |
Profit After Tax | 0 | 3 | 4 | 10 | 25 |
Adjustments | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 3 | 4 | 10 | 25 |
Adjusted Earnings Per Share | 0.2 | 10 | 6.7 | 17.5 | 33.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 117% | 151% | 0% | 0% |
Operating Profit CAGR | 175% | 0% | 0% | 0% |
PAT CAGR | 150% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 3% | NA% | NA% | NA% |
ROE Average | 32% | 83% | 83% | 83% |
ROCE Average | 34% | 65% | 50% | 50% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Shareholder's Funds | 0 | 3 | 27 | 37 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 1 | 1 | 1 | 0 |
Other Non-Current Liabilities | 0 | -0 | -0 | 0 |
Total Current Liabilities | 1 | 2 | 2 | 7 |
Total Liabilities | 2 | 6 | 30 | 44 |
Fixed Assets | 0 | 0 | 1 | 0 |
Other Non-Current Assets | 0 | 0 | 20 | 22 |
Total Current Assets | 2 | 6 | 9 | 22 |
Total Assets | 2 | 6 | 30 | 44 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 1 | 1 | 0 |
Cash Flow from Operating Activities | -0 | 0 | 0 | 5 |
Cash Flow from Investing Activities | 0 | -0 | -21 | -2 |
Cash Flow from Financing Activities | 1 | 0 | 20 | -1 |
Net Cash Inflow / Outflow | 1 | 0 | -1 | 1 |
Closing Cash & Cash Equivalent | 1 | 1 | 0 | 2 |
# | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Earnings Per Share (Rs) | 0.21 | 10 | 6.72 | 17.46 |
CEPS(Rs) | 0.21 | 10.01 | 6.87 | 17.99 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0.25 | 10.33 | 45.22 | 62.64 |
Core EBITDA Margin(%) | 1.94 | 25.39 | 15.25 | 18.13 |
EBIT Margin(%) | 1.94 | 25.37 | 14.93 | 17.63 |
Pre Tax Margin(%) | 1.93 | 25.36 | 14.88 | 17.27 |
PAT Margin (%) | 1.43 | 18.98 | 14 | 16.43 |
Cash Profit Margin (%) | 1.43 | 18.99 | 14.32 | 16.93 |
ROA(%) | 3.33 | 67.38 | 22.38 | 28.08 |
ROE(%) | 84.54 | 189.03 | 27.06 | 32.37 |
ROCE(%) | 7 | 133.26 | 26.6 | 33.83 |
Receivable days | 58.69 | 65.5 | 52.86 | 45.09 |
Inventory Days | 19.21 | 11.44 | 34.05 | 37.37 |
Payable days | 39.43 | 26.33 | 11.09 | 21.16 |
PER(x) | 0 | 0 | 12.27 | 9.18 |
Price/Book(x) | 0 | 0 | 1.82 | 2.56 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.07 | 0.04 | 1.94 | 1.66 |
EV/Core EBITDA(x) | 3.61 | 0.15 | 12.72 | 9.15 |
Net Sales Growth(%) | 0 | 252.92 | 112.08 | 121.4 |
EBIT Growth(%) | 0 | 4524.86 | 24.83 | 161.36 |
PAT Growth(%) | 0 | 4580.44 | 56.45 | 159.76 |
EPS Growth(%) | 0 | 4580.45 | -32.81 | 159.76 |
Debt/Equity(x) | 15.33 | 0.54 | 0.04 | 0.02 |
Current Ratio(x) | 2.81 | 2.82 | 4.24 | 3.22 |
Quick Ratio(x) | 2.46 | 2.5 | 2.05 | 1.99 |
Interest Cover(x) | 740 | 3013.74 | 297.22 | 48.93 |
Total Debt/Mcap(x) | 0 | 0 | 0.02 | 0.01 |
# | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|---|
Promoter | 65.59 | 66.05 | 66.05 | 66.05 | 57.81 | 57.96 |
FII | 0 | 0 | 0 | 0 | 0.03 | 0.04 |
DII | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 34.41 | 33.95 | 33.95 | 33.95 | 42.16 | 42 |
Others | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|---|
Promoter | 0.39 | 0.39 | 0.39 | 0.39 | 0.46 | 0.46 |
FII | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.21 | 0.2 | 0.2 | 0.2 | 0.34 | 0.34 |
Others | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.6 | 0.6 | 0.6 | 0.6 | 0.8 | 0.8 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About